Medicare Chartbook, 2010
This chartbook provides the most recent and reliable data available about the Medicare program and the 47 million seniors and younger people with disabilities who get health insurance coverage through the program.
View the Latest: Financing
Filter
-
-
Medicaid: A Primer on the Federal-State Partnership
Event Date:EventThis briefing provided an overview of the Medicaid program and its role in the health care system. Panelists discussed who is eligible for Medicaid, what benefits are covered, how the program is administered. Medicaid financing and the program’s role in health reform was also explained.
-
Medigap Reforms: Potential Effects of Benefit Restrictions on Medicare Spending and Beneficiary Costs
ReportAs part of several debt-reduction and Medicare-reform proposals, some policymakers propose to prohibit Medicare supplemental insurance policies (known as Medigap) from covering all of enrollees' out-of-pocket Medicare costs, which some believe leads to higher use of services and higher Medicare spending.
-
Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
ReportThis report presents findings from an analysis of the Medicare Part D marketplace in 2011 and changes in drug coverage and costs since 2006.
-
The Future of Medicare Advantage: Are We on the Right Path?
Event Date:EventThis June 10 briefing looked at Medicare Advantage and changes affecting it, including revised calculations of payments from CMS, and the Affordable Care Act's reduced payments to Medicare Advantage plans. Speakers discussed how Medicare Advantage plans are expected to respond to payment changes; if quality bonus payments created significant changes in patient care or plan choices; and what implications could these decisions have on beneficiaries with regard to premiums, benefits and more.
-
Health Care on a Budget: An Analysis of Spending by Medicare Households
ReportThis report examines Medicare beneficiaries’ out-of-pocket health care costs, which comprise a significant share of their household expenses.
-
Mapping the Donor Landscape in Global Health: Tuberculosis
ReportThis report maps the network of international assistance aimed at addressing the global impact of tuberculosis (TB). The report is part of a series that examines the donor nations and multilateral organizations involved in addressing different global health challenges in recipient countries worldwide.
-
Donor Government Funding for HIV in Low- and Middle-Income Countries in 2023
ReportThis report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2023, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).
-
In 2022, Donor Governments Spent US$8.2 billion on Efforts to Fight HIV/AIDS Globally, Returning to 2020 Funding Levels and Still Below the High-water Mark of Almost a Decade Ago
News ReleaseA new report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) reveals that donor governments disbursed US$8.2 billion in 2022 to combat HIV in low- and middle-income countries, returning to 2020 funding levels and still below the high-water mark of $8.6 billion in 2014.
-
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss
News ReleaseA KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes.